Eszter Vamos is a Senior Clinical Lecturer in Public Health Medicine at Imperial College London and an Honorary Clinical Consultant at Imperial College Healthcare NHS Trust.
Eszter studied Medicine at Semmelweis University. She was awarded the Pro Scientia Golden Award by the Hungarian National Scientific Student Council for outstanding performance in undergraduate scientific work, and obtained Distinctions at her final Medical Degree Examinations. Eszter completed her PhD at Semmelweis University in Clinical Nephrology. She was awarded two Marie Curie Fellowships by the European Commission, an Academic Clinical Fellowship by the NIHR, the Michael O’Brien Prize by the UK Faculty of Public Health for achieving the top mark in the Part A Membership Examination, and an Imperial College Clinical Lectureship by the Wellcome Trust Institutional Strategic Support fund and Imperial College London.
Eszter is the Fellow of the Higher Education Academy and leads the Population Health Improvement module of the Master of Public Health at Imperial College. She is the Chair of the Examination Board for the Global Master of Public Health (online) and also the Vice Chair of the Examination Board for the Master of Public Health.
Eszter is the Deputy Director of the Public Health Policy Evaluation Unit. Her main research interests are the epidemiology of chronic diseases particularly diabetes and cardiovascular disease, prevention of diabetes and its complications, and management of patients with established disease including risk factor control. Her areas of interest include the evaluation of health policy to prevent and manage long-term conditions. Eszter’s work is also linked to the NIHR School for Public Health Research (SPHR). The NIHR SPHR collaboration, comprising nine top research institutions, aims to build the evidence base for effective public health practice, generate knowledge that meets the needs of policy makers, practitioners and the public, and reduce health inequalities.
et al., 2023, Twenty-year trajectories of cardio-metabolic factors among people with type 2 diabetes by dementia status in England: a retrospective cohort study, European Journal of Epidemiology, Vol:38, ISSN:0393-2990, Pages:733-744
et al., 2023, Ultra-processed food consumption, cancer risk and cancer mortality: a large-scale prospective analysis within the UK Biobank, Eclinicalmedicine, Vol:56, ISSN:2589-5370, Pages:1-12
et al., 2023, Typology of how ‘harmful commodity industries’ interact with local governments in England: a critical interpretive synthesis, Bmj Global Health, Vol:8, ISSN:2059-7908, Pages:1-13
et al., 2021, Association between childhood consumption of ultraprocessed food and adiposity trajectories in the Avon Longitudinal Study of Parents and Children birth cohort, Jama Pediatrics, Vol:175, ISSN:2168-6211
et al., 2021, Ultra-processed food consumption and type 2 diabetes incidence: A prospective cohort study., Clinical Nutrition, Vol:40, ISSN:0261-5614, Pages:3608-3614
et al., 2021, Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records, The Lancet Diabetes and Endocrinology, Vol:9, ISSN:2213-8595, Pages:165-173
et al., 2012, Association of Systolic and diastolic blood pressure levels and all-cause mortality in people with newly diagnosed Type 2 diabetes: a retrospective cohort study, British Medical Journal, Vol:BMJ 2012; 345